Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Breast Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 100 articles:
HTML format
Text format



Single Articles


    January 2010
  1. PETERSON NB , Trentham-Dietz A, Garcia-Closas M, Newcomb PA, et al
    Association of COMT Haplotypes and Breast Cancer Risk in Caucasian Women.
    Anticancer Res. 2010;30:217-20.
    PubMed     Text format     Related articles    Abstract available


  2. RECCHIA F , Candeloro G, Necozione S, Accorsi P, et al
    Prolonged Disease Control after Myeloablative Chemotherapy, Autologous Transplantation and Immunotherapy in High-risk Early Breast Cancer.
    Anticancer Res. 2010;30:209-15.
    PubMed     Text format     Related articles    Abstract available


  3. HONG J , Holcomb VB, Dang F, Porampornpilas K, et al
    Alcohol consumption, obesity, estrogen treatment and breast cancer.
    Anticancer Res. 2010;30:1-8.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  4. WANG HC , Liu CS, Chiu CF, Chiang SY, et al
    Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan.
    Anticancer Res. 2009;29:5251-4.
    PubMed     Text format     Related articles    Abstract available


  5. HOFFMANN AL , Buhk JH, Strik H
    Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Anticancer Res. 2009;29:5191-5.
    PubMed     Text format     Related articles    Abstract available


  6. EATON M , Eklof J, Beal JR, Sahmoun AE, et al
    Statins and breast cancer in postmenopausal women without hormone therapy.
    Anticancer Res. 2009;29:5143-8.
    PubMed     Text format     Related articles    Abstract available


  7. ROCCA A , Cancello G, Bagnardi V, Sandri MT, et al
    Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer.
    Anticancer Res. 2009;29:5111-9.
    PubMed     Text format     Related articles    Abstract available


  8. VREKOUSSIS T , Chaniotis V, Navrozoglou I, Dousias V, et al
    Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model.
    Anticancer Res. 2009;29:4995-8.
    PubMed     Text format     Related articles    Abstract available


  9. BROWAEYS-POLY E , Perdereau D, Lescuyer A, Burnol AF, et al
    Akt interaction with PLC(gamma) regulates the G(2)/M transition triggered by FGF receptors from MDA-MB-231 breast cancer cells.
    Anticancer Res. 2009;29:4965-9.
    PubMed     Text format     Related articles    Abstract available


  10. PHIPPS SM , Love WK, White T, Andrews LG, et al
    Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells.
    Anticancer Res. 2009;29:4959-64.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  11. ISHITOBI M , Komoike Y, Motomura K, Koyama H, et al
    Retrospective Analysis of Concurrent vs. Sequential Administration of Radiotherapy and Hormone Therapy Using Aromatase Inhibitor for Hormone Receptor-positive Postmenopausal Breast Cancer.
    Anticancer Res. 2009;29:4791-4.
    PubMed     Text format     Related articles    Abstract available


  12. ESKELINEN M , Ollonen P
    Psychosocial Risk Scale (PRS) for Breast Cancer in Patients with Breast Disease: A Prospective Case-Control Study in Kuopio, Finland.
    Anticancer Res. 2009;29:4765-70.
    PubMed     Text format     Related articles    Abstract available


  13. PECTASIDES D , Psyrri A, Pliarchopoulou K, Floros T, et al
    Gastric metastases originating from breast cancer: report of 8 cases and review of the literature.
    Anticancer Res. 2009;29:4759-63.
    PubMed     Text format     Related articles    Abstract available


  14. TILLE JC , Egger JF, Devillaz MC, Vlastos G, et al
    Frozen section in axillary sentinel lymph nodes for diagnosis of breast cancer micrometastasis.
    Anticancer Res. 2009;29:4711-6.
    PubMed     Text format     Related articles    Abstract available


  15. XU P , Ye W, Jen R, Lin SH, et al
    Mitogenic activity of zeranol in human breast cancer cells is enhanced by leptin and suppressed by gossypol.
    Anticancer Res. 2009;29:4621-8.
    PubMed     Text format     Related articles    Abstract available



  16. Breast cancer in the post-genomic era.
    Anticancer Res. 2009;29:29.
    PubMed     Text format     Related articles   


    October 2009
  17. MARTIN M , Garcia-Saenz JA, DE Las Casas ML, Vidaurreta M, et al
    Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
    Anticancer Res. 2009;29:4185-7.
    PubMed     Text format     Related articles    Abstract available


  18. FERRONI P , Palmirotta R, Martini F, Riondino S, et al
    Determinants of homocysteine levels in colorectal and breast cancer patients.
    Anticancer Res. 2009;29:4131-8.
    PubMed     Text format     Related articles    Abstract available


  19. MATHELIN C , Croce S, Brasse D, Gairard B, et al
    Methylene blue dye, an accurate dye for sentinel lymph node identification in early breast cancer.
    Anticancer Res. 2009;29:4119-25.
    PubMed     Text format     Related articles    Abstract available


  20. MATSUMOTO M , Sakamoto H, Yamaguchi Y, Seino Y, et al
    3-Dimensional Microarray Analysis of Estrogen Signal-related Genes in Breast Cancer Tissues.
    Anticancer Res. 2009;29:3971-5.
    PubMed     Text format     Related articles    Abstract available


  21. HELLER G , Ziegler B, Brandstetter A, Novak S, et al
    CDK10 Is Not a Target for Aberrant DNA Methylation in Breast Cancer.
    Anticancer Res. 2009;29:3939-44.
    PubMed     Text format     Related articles    Abstract available


  22. YOM CK , Woo HY, Min SY, Kang SY, et al
    Clusterin Overexpression and Relapse-free Survival in Breast Cancer.
    Anticancer Res. 2009;29:3909-12.
    PubMed     Text format     Related articles    Abstract available


  23. WANG HC , Chiu CF, Tsai RY, Kuo YS, et al
    Association of Genetic Polymorphisms of EXO1 Gene with Risk of Breast Cancer in Taiwan.
    Anticancer Res. 2009;29:3897-3901.
    PubMed     Text format     Related articles    Abstract available


  24. DAY TW , Sinn AL, Huang S, Pollok KE, et al
    c-FLIP Gene Silencing Eliminates Tumor Cells in Breast Cancer Xenografts Without Affecting Stromal Cells.
    Anticancer Res. 2009;29:3883-6.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  25. VANOIRBEEK E , Eelen G, Verlinden L, Marchal K, et al
    Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analog.
    Anticancer Res. 2009;29:3585-90.
    PubMed     Text format     Related articles    Abstract available


  26. HUSSAIN-HAKIMJEE EA , Mehta RG
    Regulation of steroid receptor expression by 1alpha-hydroxyvitamin D5 in hormone-responsive breast cancer cells.
    Anticancer Res. 2009;29:3555-61.
    PubMed     Text format     Related articles    Abstract available


  27. FISCHER D , Becker S, Cordes T, Bucker B, et al
    Vitamin D-24-hydroxylase in benign and malignant breast tissue and cell lines.
    Anticancer Res. 2009;29:3641-5.
    PubMed     Text format     Related articles    Abstract available


  28. THILL M , Fischer D, Becker S, Cordes T, et al
    Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.
    Anticancer Res. 2009;29:3619-25.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  29. GORDIAN E , Ramachandran K, Singal R
    Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity.
    Anticancer Res. 2009;29:3207-10.
    PubMed     Text format     Related articles    Abstract available


  30. CHANG HL , Sugimoto Y, Liu S, Wang LS, et al
    Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Anticancer Res. 2009;29:3195-205.
    PubMed     Text format     Related articles    Abstract available


  31. DELLA ROVERE F , Granata A, Monaco M, Basile G, et al
    Phagocytosis of cancer cells by mast cells in breast cancer.
    Anticancer Res. 2009;29:3157-61.
    PubMed     Text format     Related articles    Abstract available


  32. FU OY , Hou MF, Yang SF, Huang SC, et al
    Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
    Anticancer Res. 2009;29:3131-8.
    PubMed     Text format     Related articles    Abstract available


  33. KOVAR J , Ehrlichova M, Smejkalova B, Zanardi I, et al
    Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.
    Anticancer Res. 2009;29:2951-60.
    PubMed     Text format     Related articles    Abstract available


  34. TAKEUCHI H , Muto Y, Tashiro H
    Clinicopathological characteristics of recurrence more than 10 years after surgery in patients with breast carcinoma.
    Anticancer Res. 2009;29:3445-8.
    PubMed     Text format     Related articles    Abstract available


  35. MELICHAR B , Kalabova H, Krcmova L, Urbanek L, et al
    Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma.
    Anticancer Res. 2009;29:3337-46.
    PubMed     Text format     Related articles    Abstract available


  36. STACHTEA X , Karamanos N, Klouras N
    Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
    Anticancer Res. 2009;29:3227-31.
    PubMed     Text format     Related articles    Abstract available


  37. HARTMANN J , Getoff N
    Effect of free radicals on the biological action of genistein in vitro and synergism with mitomycin C.
    Anticancer Res. 2009;29:3179-83.
    PubMed     Text format     Related articles    Abstract available


  38. SAUSSEDE-AIM J , Matera EL, Herveau S, Rouault JP, et al
    Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site.
    Anticancer Res. 2009;29:3003-9.
    PubMed     Text format     Related articles    Abstract available


  39. BADISA RB , Darling-Reed SF, Joseph P, Cooperwood JS, et al
    Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells.
    Anticancer Res. 2009;29:2993-6.
    PubMed     Text format     Related articles    Abstract available


  40. WANG CZ , Li XL, Sun S, Xie JT, et al
    Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
    Anticancer Res. 2009;29:2927-32.
    PubMed     Text format     Related articles    Abstract available


  41. AHN EH , Chang CC, Talmage DA
    Loss of anti-proliferative effect of all-trans retinoic acid in advanced stage of breast carcinogenesis.
    Anticancer Res. 2009;29:2899-904.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  42. POLYZOS A , Gogas H, Markopoulos C, Tsavaris N, et al
    Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.
    Anticancer Res. 2009;29:2851-6.
    PubMed     Text format     Related articles    Abstract available


  43. DIVELLA R , Tommasi S, Lacalamita R, Daniele A, et al
    Circulating hTERT DNA in Early Breast Cancer.
    Anticancer Res. 2009;29:2845-9.
    PubMed     Text format     Related articles    Abstract available


  44. SIMMONS C , Amir E, Dranitsaris G, Clemons M, et al
    Altered Calcium Metabolism in Patients on Long-term Bisphosphonate Therapy for Metastatic Breast Cancer.
    Anticancer Res. 2009;29:2707-11.
    PubMed     Text format     Related articles    Abstract available


  45. WARM M , Kates R, Thomas A, Fischer T, et al
    Side-effects of Pre-operative Epirubicin-Paclitaxel Therapy in Primary Breast Cancer Associated with Tumor Biology.
    Anticancer Res. 2009;29:2675-80.
    PubMed     Text format     Related articles    Abstract available


  46. MATKOWSKI R , Gisterek I, Halon A, Lacko A, et al
    The Prognostic Role of Tumor-infiltrating CD4 and CD8 T Lymphocytes in Breast Cancer.
    Anticancer Res. 2009;29:2445-51.
    PubMed     Text format     Related articles    Abstract available


  47. CAMARA O , Herrmann J, Egbe A, Koch I, et al
    Venous coupler for free-flap anastomosis.
    Anticancer Res. 2009;29:2827-30.
    PubMed     Text format     Related articles    Abstract available


  48. CAMARA O , Egbe A, Koch I, Herrmann J, et al
    Surgical management of multiple bilateral fibroadenoma of the breast: the Ribeiro technique modified by Rezai.
    Anticancer Res. 2009;29:2823-6.
    PubMed     Text format     Related articles    Abstract available


  49. PROSCHEK D , Kurth A, Proschek P, Vogl TJ, et al
    Prospective pilot-study of combined bipolar radiofrequency ablation and application of bone cement in bone metastases.
    Anticancer Res. 2009;29:2787-92.
    PubMed     Text format     Related articles    Abstract available


  50. LOO WT , Chow LW, Suzuki T, Ono K, et al
    Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues.
    Anticancer Res. 2009;29:2525-30.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  51. SMOLLICH M , Gotte M, Fischgrabe J, Radke I, et al
    Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
    Anticancer Res. 2009;29:2167-71.
    PubMed     Text format     Related articles    Abstract available


  52. TANAKA H , Nakamura M, Kameda C, Kubo M, et al
    The Hedgehog Signaling Pathway Plays an Essential Role in Maintaining the CD44+CD24-/low Subpopulation and the Side Population of Breast Cancer Cells.
    Anticancer Res. 2009;29:2147-57.
    PubMed     Text format     Related articles    Abstract available


  53. RAUSCH MP , Hahn T, Ramanathapuram L, Bradley-Dunlop D, et al
    An Orally Active Small Molecule TGF-{beta} Receptor I Antagonist Inhibits the Growth of Metastatic Murine Breast Cancer.
    Anticancer Res. 2009;29:2099-109.
    PubMed     Text format     Related articles    Abstract available


  54. PEYRI N , Berard M, Fauvel-Lafeve F, Trochon V, et al
    Breast tumor cells transendothelial migration induces endothelial cell anoikis through extracellular matrix degradation.
    Anticancer Res. 2009;29:2347-55.
    PubMed     Text format     Related articles    Abstract available


  55. JANECKOVA H , Vesely P, Chmelik R
    Proving tumour cells by acute nutritional/energy deprivation as a survival threat: a task for microscopy.
    Anticancer Res. 2009;29:2339-45.
    PubMed     Text format     Related articles    Abstract available


  56. MARTSCHICK A , Sehouli J, Patzelt A, Richter H, et al
    The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesia.
    Anticancer Res. 2009;29:2307-13.
    PubMed     Text format     Related articles    Abstract available


  57. RAGAZZON PA , Iley J, Missailidis S
    Structure-activity studies of the binding of the flavonoid scaffold to DNA.
    Anticancer Res. 2009;29:2285-93.
    PubMed     Text format     Related articles    Abstract available


  58. RAGAZZON PA , Bradshaw T, Matthews C, Iley J, et al
    The characterisation of flavone-DNA isoform interactions as a basis for anticancer drug development.
    Anticancer Res. 2009;29:2273-83.
    PubMed     Text format     Related articles    Abstract available


  59. AZMI PB , Seth AK
    The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.
    Anticancer Res. 2009;29:2253-63.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  60. VICI P , Giotta F, DI Lauro L, Brandi M, et al
    Multicenter Phase II Trial of First-line Docetaxel/Gemcitabine in Advanced Breast Cancer Pretreated with Adjuvant Anthracyclines.
    Anticancer Res. 2009;29:1841-5.
    PubMed     Text format     Related articles    Abstract available


  61. ABDALLA F , Boder J, Markus R, Hashmi H, et al
    Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
    Anticancer Res. 2009;29:1771-6.
    PubMed     Text format     Related articles    Abstract available


  62. TAGUCHI K , Iihara H, Ishihara M, Komori Y, et al
    Comparison of Antiemetic Efficacy between Single and Repeated Treatments with a 5-HT3 Receptor Antagonist in Breast Cancer Patients with High-risk Emetogenic Chemotherapy.
    Anticancer Res. 2009;29:1721-5.
    PubMed     Text format     Related articles    Abstract available


  63. JAFFRE F , Lavoue V, Mesbah H, Rouquette S, et al
    Prognosis for isolated skin recurrence after breast cancer treated by mastectomy.
    Anticancer Res. 2009;29:1697-701.
    PubMed     Text format     Related articles    Abstract available


  64. MIGLIETTA L , Vanella P, Canobbio L, Parodi MA, et al
    Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, her2 status, grading and ki-67 proliferation index.
    Anticancer Res. 2009;29:1621-5.
    PubMed     Text format     Related articles    Abstract available


  65. NIO Y , Iguchi C, Itakura M, Toga T, et al
    High Incidence of Synchronous or Metachronous Breast Cancer in Patients with Malignant and Benign Thyroid Tumor or Tumor-like Disorders.
    Anticancer Res. 2009;29:1607-10.
    PubMed     Text format     Related articles    Abstract available


  66. BROOM RJ , Tang PA, Simmons C, Bordeleau L, et al
    Changes in estrogen receptor, progesterone receptor and her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
    Anticancer Res. 2009;29:1557-62.
    PubMed     Text format     Related articles    Abstract available


  67. ISHIKAWA T , Shimizu S, Katayama K, Chishima T, et al
    Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan.
    Anticancer Res. 2009;29:1515-20.
    PubMed     Text format     Related articles    Abstract available


  68. DE CREMOUX P , Grandin L, Dieras V, Savignoni A, et al
    Urokinase-type Plasminogen Activator and Plasminogen-activator-inhibitor Type 1 Predict Metastases in Good Prognosis Breast Cancer Patients.
    Anticancer Res. 2009;29:1475-1482.
    PubMed     Text format     Related articles    Abstract available


  69. BUONOMO O , Orsaria P, Contino G, Varvaras D, et al
    Pathological classification of DCIS and planning of therapeutic management.
    Anticancer Res. 2009;29:1499-506.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  70. OKARVI SM , Jammaz IA
    Design, Synthesis, Radiolabeling and In Vitro and In Vivo Characterization of Tumor-antigen- and Antibody-derived Peptides for the Detection of Breast Cancer.
    Anticancer Res. 2009;29:1399-409.
    PubMed     Text format     Related articles    Abstract available


  71. SEIFEDDINE R , Fulchignoni-Lataud MC, Massaad-Massade L
    Down-regulation of C/EBP{alpha} in Breast Cancer Cells by Hypoxia-Estrogen Combination is Mainly Due to Hypoxia.
    Anticancer Res. 2009;29:1227-31.
    PubMed     Text format     Related articles    Abstract available


  72. SHEEN-CHEN SM , Zhang H, Huang CC, Tang RP, et al
    Insulin-like Growth Factor-binding Protein-3 in Breast Cancer: Analysis with Tissue Microarray.
    Anticancer Res. 2009;29:1131-5.
    PubMed     Text format     Related articles    Abstract available


  73. KULENDRAN M , Salhab M, Mokbel K
    Oestrogen-synthesising enzymes and breast cancer.
    Anticancer Res. 2009;29:1095-109.
    PubMed     Text format     Related articles    Abstract available


  74. KATAYAMA K , Shibata K, Mitsuhashi J, Noguchi K, et al
    Pharmacological Interplay between Breast Cancer Resistance Protein and Gefitinib in Epidermal Growth Factor Receptor Signaling.
    Anticancer Res. 2009;29:1059-65.
    PubMed     Text format     Related articles    Abstract available


  75. AUGUSTIN S , Berard M, Kellaf S, Peyri N, et al
    Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells.
    Anticancer Res. 2009;29:1335-43.
    PubMed     Text format     Related articles    Abstract available


  76. KIM SH , Zukowski K, Novak RF
    Rapamycin effects on mTOR signaling in benign, premalignant and malignant human breast epithelial cells.
    Anticancer Res. 2009;29:1143-50.
    PubMed     Text format     Related articles    Abstract available


  77. SHIMADA T , Ueda M, Jinno H, Chiba N, et al
    Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
    Anticancer Res. 2009;29:1009-14.
    PubMed     Text format     Related articles    Abstract available


  78. WEIDLE UH , Evtimova V, Alberti S, Guerra E, et al
    Cell growth stimulation by CRASH, an asparaginase-like protein overexpressed in human tumors and metastatic breast cancers.
    Anticancer Res. 2009;29:951-63.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  79. KAMEDA C , Tanaka H, Yamasaki A, Nakamura M, et al
    The Hedgehog Pathway Is a Possible Therapeutic Target for Patients with Estrogen Receptor-negative Breast Cancer.
    Anticancer Res. 2009;29:871-9.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  80. FINEK J , Holubec L Jr, Svoboda T, Sefrhansova L, et al
    A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer.
    Anticancer Res. 2009;29:667-70.
    PubMed     Text format     Related articles    Abstract available


  81. HORIGUCHI J , Rai Y, Tamura K, Taki T, et al
    Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Anticancer Res. 2009;29:625-30.
    PubMed     Text format     Related articles    Abstract available


  82. HORIGUCHI J , Oyama T, Koibuchi Y, Yokoe T, et al
    Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancer.
    Anticancer Res. 2009;29:517-24.
    PubMed     Text format     Related articles    Abstract available


  83. LUMACHI F , Borsato S, Tregnaghi A, Ferretti G, et al
    Usefulness of combined sestamibi scintimammography, axillary ultrasonography and FNA cytology in reducing the number of sentinel node procedures in patients with early-stage breast cancer.
    Anticancer Res. 2009;29:491-4.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  84. DRAPEAU C , Ma H, Yang Z, Tang L, et al
    The stem cell mobilizer StemEnhance does not promote tumor growth in an orthotopic model of human breast cancer.
    Anticancer Res. 2009;29:443-7.
    PubMed     Text format     Related articles    Abstract available


  85. KANAAN YM , Das JR, Bakare O, Enwerem NM, et al
    Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
    Anticancer Res. 2009;29:191-9.
    PubMed     Text format     Related articles    Abstract available


  86. KNIPPEN S , Loning T, Muller V, Schroder C, et al
    Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.
    Anticancer Res. 2009;29:183-9.
    PubMed     Text format     Related articles    Abstract available


  87. MCCARTHY K , Laban C, Bustin SA, Ogunkolade W, et al
    Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue.
    Anticancer Res. 2009;29:155-7.
    PubMed     Text format     Related articles    Abstract available


  88. ENGEBRAATEN O , Trikha M, Juell S, Garman-Vik S, et al
    Inhibition of in vive tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins.
    Anticancer Res. 2009;29:131-7.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  89. HIRANO A , Shimizu T, Watanabe O, Kinoshita J, et al
    Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  90. PATANI N , Jouhra F, Jiang W, Mokbel K, et al
    Osteopontin expression profiles predict pathological and clinical outcome in breast cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  91. CAMPORA E , Colloca G, Ratti R, Addamo G, et al
    Docetaxel for metastatic breast cancer: two consecutive phase II trials.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  92. NIIBE Y , Kuranami M, Matsunaga K, Takaya M, et al
    Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  93. CHEAH YH , Nordin FJ, Tee TT, Azimahtol HL, et al
    Antiproliferative property and apoptotic effect of xanthorrhizol on MDA-MB-231 breast cancer cells.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  94. ABDALLA F , Boder J, Buhmeida A, Hashmi H, et al
    Nuclear morphometry in FNABs of breast disease in Libyans.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  95. MEYER A , Steinmann D, Malaimare L, Karstens JH, et al
    Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  96. PUIG T , Relat J, Marrero PF, Haro D, et al
    Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  97. SCHNEUBER SE , Scholz HS, Regitnig P, Petru E, et al
    Breast metastasis 56 months before the diagnosis of primary ovarian cancer: a case study.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  98. ASMANE I , Litique V, Heymann S, Marcellin L, et al
    Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literature.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  99. NIEDER C , Geinitz H, Molls M
    Validation of the graded prognostic assessment index for surgically treated patients with brain metastases.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


  100. CALZOLARI F , Sartori PV, Talarico C, Parmeggiani D, et al
    Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: